Log In
Print
BCIQ
Print
Print this Print this
 

KTN3379

  Manage Alerts
Collapse Summary General Information
Company Kolltan Pharmaceuticals Inc.
DescriptionHuman mAb against epidermal growth factor receptor 3 (EGFR3; HER3; ErbB3)
Molecular Target Epidermal growth factor receptor 3 (EGFR3) (HER3) (ErbB3)
Mechanism of ActionAntibody; Epidermal growth factor (EGF) receptor 3 (HER3) (ErbB3) inhibitor
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today